Filter News
Area of Research
- (-) Neutron Science (3)
- Advanced Manufacturing (4)
- Biology and Environment (64)
- Biology and Soft Matter (1)
- Building Technologies (1)
- Clean Energy (56)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (4)
- Isotopes (3)
- Materials (14)
- Materials for Computing (7)
- Mathematics (1)
- National Security (11)
- Supercomputing (28)
News Type
News Topics
- (-) Biomedical (2)
- (-) Environment (1)
- (-) Frontier (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (4)
- Biology (4)
- Chemical Sciences (1)
- Computer Science (5)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (2)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (7)
- Microscopy (1)
- Nanotechnology (2)
- National Security (1)
- Neutron Science (24)
- Physics (2)
- Quantum Computing (1)
- Quantum Science (3)
- Security (1)
- Space Exploration (2)
- Summit (1)
- Transportation (1)
Media Contacts
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.